Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Marketable Securities: ¥0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920344 Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
83 GF Score
Price ¥18.90
GF Value ¥20.89
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Beijing Tri Prime Gene Pharmaceutical Co Marketable Securities?

Beijing Tri Prime Gene Pharmaceutical Co BJSE:920344 83 Marketable Securities is ¥0.0 Mil as of Jun. 2026. GuruFocus rates BJSE:920344 with a GF Score™ of 83/100 and a GF Value™ of ¥20.89 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Beijing Tri Prime Gene Pharmaceutical Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥0.0 Mil.

Beijing Tri Prime Gene Pharmaceutical Co  (BJSE:920344) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Beijing Tri Prime Gene Pharmaceutical Co Marketable Securities Related Terms

Beijing Tri Prime Gene Pharmaceutical Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Beijing Tri Prime Gene Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tri Prime Gene Pharmaceutical Co Marketable Securities Chart

Beijing Tri Prime Gene Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Beijing Tri Prime Gene Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BJSE:920344
83GF Score
Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tri Prime Gene Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥0.0 Mil mean?
Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) has a Marketable Securities of ¥0.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Beijing Tri Prime Gene Pharmaceutical Co and its competitors.
Is Beijing Tri Prime Gene Pharmaceutical Co's Marketable Securities too high?
Beijing Tri Prime Gene Pharmaceutical Co's current Marketable Securities is ¥0.0 Mil. Overall, Beijing Tri Prime Gene Pharmaceutical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tri Prime Gene Pharmaceutical Co's Marketable Securities compare to VRTX and REGN?
Beijing Tri Prime Gene Pharmaceutical Co's Marketable Securities of ¥0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Beijing Tri Prime Gene Pharmaceutical Co and its competitors. Beijing Tri Prime Gene Pharmaceutical Co's current Marketable Securities is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tri Prime Gene Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.89, compared to a current price of ¥18.90 — trading 9.5% below its estimated fair value. The current Marketable Securities is ¥0.0 Mil. Beijing Tri Prime Gene Pharmaceutical Co's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344), the current Marketable Securities is ¥0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥18.90 is trading 9.5% below its estimated GF Value™ of ¥20.89. GuruFocus considers Beijing Tri Prime Gene Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920344:

  • Marketable Securities: ¥0.0 Mil
  • GF Value™: ¥20.89 vs. price of ¥18.90 (9.5% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920344 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tri Prime Gene Pharmaceutical Co Business Description

Address No. 20, Jinghong Street, Biomedicine Base, Daxing District, Beijing, CHN, 102600
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products, including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and is engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, and Yundexol Water Injection.
83GF Score

Get the complete analysis for BJSE:920344

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.90
Price
¥20.89
GF Value